Literature DB >> 24588212

Reply: hormonally targeted therapy for women with lymphangioleiomyomatosis.

Jane Yu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24588212      PMCID： PMC6223091          DOI： 10.1165/rcmb.2013-0324LE

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN： 1044-1549            Impact factor:   6.914


× No keyword cloud information.
  3 in total

1.  Faslodex inhibits estradiol-induced extracellular matrix dynamics and lung metastasis in a model of lymphangioleiomyomatosis.

Authors:  Chenggang Li; Xiaobo Zhou; Yang Sun; Erik Zhang; John D Mancini; Andrey Parkhitko; Tasha A Morrison; Edwin K Silverman; Elizabeth P Henske; Jane J Yu
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

2.  Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells.

Authors:  Jane J Yu; Victoria A Robb; Tasha A Morrison; Eric A Ariazi; Magdalena Karbowniczek; Aristotelis Astrinidis; Chunrong Wang; Lisa Hernandez-Cuebas; Laura F Seeholzer; Emmanuelle Nicolas; Harvey Hensley; V Craig Jordan; Cheryl L Walker; Elizabeth P Henske
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-06       Impact factor: 11.205

3.  Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways.

Authors:  Jane Yu; Aristotelis Astrinidis; Sharon Howard; Elizabeth Petri Henske
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-08-15       Impact factor: 5.464
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.